Correlation of toxoplasmosis with small‑for‑gestational‑age newborns.

Background: Toxoplasma gondii infection in pregnant women could lead to significant changes during the pregnancy, affect the outcomes of pregnancy and the timing of labour. Small‑for‑gestational‑age (SGA) newborns are defined by birthweight below the 10th percentile for gestational age. We tested an association between latent toxoplasmosis in pregnant women and deliveries of SGA babies.

Slide plasty of trachea and right main bronchus in a newborn.

Congenital stenosis of airways is a rare and possibly life-threatening congenital defect with difficult treatment and uncertain prognosis. In our report, we describe a rare case of a 1-month-old newborn with concomitant stenosis of trachea and main bronchus and its successful treatment using slide plasty.

Attitudes of stakeholders towards the Podyji/Thaya River Basin National Park in the Czech Republic.

In August 2000, a survey of public opinion was carried out among visitors, local residents and representatives of local self-governments in the territory of the Podyji/Thaya River Basin National Park in the Czech Republic. The goal was to obtain stakeholders' opinions and attitudes towards nature conservation, the National Park and tourism within the territory which used to be closed to the public for 40 years due to the Iron Curtain. Without the knowledge of opinions of stakeholders it is not possible to manage nature conservation and development in the protected area properly.

Current methods in the treatment of posthemorrhagic hydrocephalus in infants.

The authors reviewed the most recent methods and approaches in the management of posthemorrhagic hydrocephalus in infants. Posthemorrhagic hydrocephalus in infants is associated with a high mortality and morbidity. The incidence of developmental delay, cerebral palsy, epilepsy end visual impairment in surviving children is variable.

Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection.

Background: Palivizumab reduces respiratory syncytial virus (RSV) hospitalisations in high-risk infants. Those with severe bronchopulmonary dysplasia may require two seasons of prophylaxis. There is concern that this humanised antibody might cause an adverse immune response in a second season of use.